Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.492
Filtrar
1.
Sci Rep ; 14(1): 12374, 2024 05 29.
Artigo em Inglês | MEDLINE | ID: mdl-38811642

RESUMO

Circulating tumor cells (CTCs) have gathered attention as a biomarker for carcinomas. However, CTCs in sarcomas have received little attention. In this work, we investigated cell surface proteins and antibody combinations for immunofluorescence detection of sarcoma CTCs. A microfluidic device that combines filtration and immunoaffinity using gangliosides 2 and cell surface vimentin (CSV) antibodies was employed to capture CTCs. For CTC detection, antibodies against cytokeratins 7 and 8 (CK), pan-cytokeratin (panCK), or a combination of panCK and CSV were used. Thirty-nine blood samples were collected from 21 patients of various sarcoma subtypes. In the independent samples study, samples were subjected to one of three antibody combination choices. Significant difference in CTC enumeration was found between CK and panCK + CSV, and between panCK and panCK + CSV. Upon stratification of CK+ samples, those of metastatic disease had a higher CTC number than those of localized disease. In the paired samples study involving cytokeratin-positive sarcoma subtypes, using panCK antibody detected more CTCs than CK. Similarly, for osteosarcoma, using panCK + CSV combination resulted in a higher CTC count than panCK. This study emphasized deliberate selection of cell surface proteins for sarcoma CTC detection and subtype stratification for studying cancers as heterogeneous as sarcomas.


Assuntos
Biomarcadores Tumorais , Células Neoplásicas Circulantes , Sarcoma , Humanos , Células Neoplásicas Circulantes/patologia , Células Neoplásicas Circulantes/metabolismo , Sarcoma/patologia , Sarcoma/sangue , Sarcoma/diagnóstico , Sarcoma/metabolismo , Biomarcadores Tumorais/sangue , Feminino , Masculino , Proteínas de Membrana/metabolismo , Proteínas de Membrana/imunologia , Queratinas/imunologia , Queratinas/metabolismo , Pessoa de Meia-Idade , Adulto , Vimentina/metabolismo , Vimentina/imunologia , Idoso , Anticorpos/imunologia , Linhagem Celular Tumoral
2.
FASEB J ; 36(5): e22322, 2022 05.
Artigo em Inglês | MEDLINE | ID: mdl-35429062

RESUMO

Emerging evidence suggests that signaling through the C3a anaphylatoxin receptor (C3aR) protects against various inflammation-related diseases. However, the role of C3aR in psoriasis remains unknown. The purpose of this study was to investigate the possible protective role of C3aR in psoriasis and to explore the underlying molecular mechanisms. We initially found that the psoriatic epidermis exhibited significantly decreased C3aR expression. C3aR showed protective roles in mouse models of imiquimod (IMQ)- and interleukin-23-induced psoriasis. Furthermore, increased epidermal thickness and keratin 6 (K6), K16, and K17 expression occurred in the ears and backs of C3aR-/- mice. Pharmacological treatment with a C3aR agonist ameliorated IMQ-induced psoriasiform lesions in mice and decreased the expression of K6, K16, and K17. Additionally, the signal transducer and activator of transcription 3 (STAT3) pathway participated in the protective function of C3aR. More importantly, the expression levels of K6, K16, and K17 in keratinocytes were all restored in HaCaT cells transfected with a C3aR-overexpression plasmid after treating them with colivelin (a STAT3 activator). Our findings demonstrate that C3aR protects against the development of psoriasis and suggest that C3aR confers protection by negatively regulating K6, K16, and K17 expression in a STAT3-dependent manner, thus inhibiting keratinocyte proliferation and helping reverse the pathogenesis of psoriasis.


Assuntos
Queratinócitos , Queratinas , Psoríase , Receptores Acoplados a Proteínas G , Anafilatoxinas , Animais , Proliferação de Células , Modelos Animais de Doenças , Queratina-16/imunologia , Queratina-17/imunologia , Queratina-6/imunologia , Queratinócitos/metabolismo , Queratinócitos/patologia , Queratinas/imunologia , Camundongos , Psoríase/tratamento farmacológico , Psoríase/imunologia , Psoríase/patologia , Receptores Acoplados a Proteínas G/imunologia , Pele/metabolismo
3.
J Med Microbiol ; 70(5)2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33956590

RESUMO

Introduction. Group A streptococci can trigger autoimmune responses that lead to acute rheumatic fever (ARF) and rheumatic heart disease (RHD).Gap Statement. Some autoantibodies generated in ARF/RHD target antigens in the S2 subfragment region of cardiac myosin. However, little is known about the kinetics of these antibodies during the disease process.Aim. To determine the antibody responses over time in patients and healthy controls against host tissue proteins - cardiac myosin and peptides from its S2 subfragment, tropomyosin, laminin and keratin.Methodology. We used enzyme-linked immunosorbent assays (ELISA) to determine antibody responses in: (1) healthy controls; (2) patients with streptococcal pharyngitis; (3) patients with ARF with carditis and (4) patients with RHD on penicillin prophylaxis.Results. We observed significantly higher antibody responses against extracellular proteins - laminin and keratin in pharyngitis group, patients with ARF and patients with RHD when compared to healthy controls. The antibody responses against intracellular proteins - cardiac myosin and tropomyosin were elevated only in the group of patients with ARF with active carditis. While the reactivity to S2 peptides S2-1-3, 8-11, 14, 16-18, 21-22 and 32 was higher in patients with ARF, the reactivity in the RHD group was high only against S2-1, 9, 11, 12 when compared to healthy controls. The reactivity against S2 peptides reduced as the disease condition stabilized in the ARF group whereas the reactivity remained unaltered in the RHD group. By contrast antibodies against laminin and keratin persisted in patients with RHD.Conclusion. Our findings of antibody responses against host proteins support the multistep hypothesis in the development of rheumatic carditis. The differential kinetics of serum antibody responses against S2 peptides may have potential use as markers of ongoing cardiac damage that can be used to monitor patients with ARF/RHD.


Assuntos
Autoanticorpos/imunologia , Autoantígenos/imunologia , Febre Reumática/imunologia , Cardiopatia Reumática/imunologia , Autoanticorpos/sangue , Autoantígenos/química , Miosinas Cardíacas/química , Miosinas Cardíacas/imunologia , Humanos , Queratinas/imunologia , Laminina/imunologia , Estudos Longitudinais , Peptídeos/química , Peptídeos/imunologia , Febre Reumática/sangue , Cardiopatia Reumática/sangue , Infecções Estreptocócicas/sangue , Infecções Estreptocócicas/imunologia , Streptococcus pyogenes/imunologia , Tropomiosina/imunologia
5.
Int J Mol Sci ; 21(12)2020 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-32580421

RESUMO

Cancer risk prognosis could improve patient survival through early personalized treatment decisions. This is the first systematic analysis of the spatial and prognostic distribution of different pan cytokeratin immunostaining intensities in breast tumors. The prognostic model included 102 breast carcinoma patients, with distant metastasis occurrence as the endpoint. We segmented the full intensity range (0-255) of pan cytokeratin digitized immunostaining into seven discrete narrow grey level ranges: 0-130, 130-160, 160-180, 180-200, 200-220, 220-240, and 240-255. These images were subsequently examined by 33 major (GLCM), fractal and first-order statistics computational analysis features. Interestingly, while moderate intensities were strongly associated with metastasis outcome, high intensities of pan cytokeratin immunostaining provided no prognostic value even after an exhaustive computational analysis. The intense pan cytokeratin immunostaining was also relatively rare, suggesting the low differentiation state of epithelial cells. The observed variability in immunostaining intensities highlighted the intratumoral heterogeneity of the malignant cells and its association with a poor disease outcome. The prognostic importance of the moderate intensity range established by complex computational morphology analyses was supported by simple measurements of its immunostaining area which was associated with favorable disease outcome. This study reveals intratumoral heterogeneity of the pan cytokeratin immunostaining together with the prognostic evaluation and spatial distribution of its discrete intensities.


Assuntos
Biomarcadores Tumorais/metabolismo , Neoplasias da Mama/patologia , Queratinas/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias da Mama/imunologia , Neoplasias da Mama/metabolismo , Feminino , Seguimentos , Humanos , Queratinas/imunologia , Pessoa de Meia-Idade , Prognóstico , Receptor ErbB-2/metabolismo , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Análise Espacial
6.
Diagn Cytopathol ; 48(11): 1107-1110, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32472960

RESUMO

Adamantinoma-like Ewing Sarcoma (ALES) is a rare subtype of Ewing sarcoma family of tumors (EFTs) which are defined by their EWSR1 gene rearrangements. We present a case of a 15-year old female with a swelling in her anterior neck of 4 months duration which had recently begun to rapidly grow in size. Fine needle aspiration showed a small blue round cell tumor with immunoreactivity for cytokeratin, CD99 and FLI1. Material for molecular testing was available on the resection specimen. Demonstration of t(11;22) (EWS-FLI1) was helpful in establishing the diagnosis.


Assuntos
Adamantinoma/diagnóstico , Neoplasias de Cabeça e Pescoço/diagnóstico , Sarcoma de Ewing/diagnóstico , Glândula Tireoide/patologia , Antígeno 12E7/imunologia , Adamantinoma/patologia , Adolescente , Biomarcadores Tumorais/imunologia , Biópsia por Agulha Fina/métodos , Diagnóstico Diferencial , Feminino , Neoplasias de Cabeça e Pescoço/patologia , Neoplasias de Cabeça e Pescoço/cirurgia , Humanos , Hibridização in Situ Fluorescente , Queratinas/imunologia , Proteínas de Fusão Oncogênica/análise , Proteína Proto-Oncogênica c-fli-1/análise , Proteína Proto-Oncogênica c-fli-1/imunologia , Proteína EWS de Ligação a RNA/análise , Proteína EWS de Ligação a RNA/genética , Sarcoma de Ewing/patologia , Sarcoma de Ewing/cirurgia , Glândula Tireoide/cirurgia , Tireoidectomia
7.
Vet Pathol ; 57(3): 377-387, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-32100640

RESUMO

Feline mammary tumors are usually malignant and aggressive carcinomas. Most cases are simple monophasic carcinomas (1 epithelial population), and additional phenotyping is usually not needed. In this study, we describe 10 malignant mammary tumors from 9 female cats that had unusual histomorphology: they appeared biphasic, with 2 distinct cell populations. Initially, they were morphologically diagnosed as either carcinosarcoma (1/10) or malignant pleomorphic tumor (9/10) of the mammary gland, as the latter did not match any previously described histological subtype. Immunohistochemistry (IHC) was performed for pancytokeratin, cytokeratins 8 and 18, cytokeratin 14, cytokeratins 5 and 6, vimentin, p63, calponin, alpha-smooth muscle actin, Ki-67, ERBB2, estrogen receptor alpha, and progesterone receptor. In 7 of 10 cases, the biphasic nature was confirmed and, on the basis of the IHC results, they were classified as carcinoma and malignant myoepithelioma (4/10), ductal carcinoma (1/10), and carcinosarcoma (2/10). The other 3 of 10 cases were monophasic based on IHC. In the cases of carcinoma and malignant myoepithelioma, the malignant myoepithelial cells were 100% positive for vimentin (4/4) and variably positive for p63, calponin, and cytokeratins (4/4). These findings show that, although rare, biphasic mammary carcinomas do occur in cats. In dogs and humans, tumors composed of malignant epithelial and myoepithelial cells have a less aggressive behavior than certain simple carcinomas, and therefore, their identification might also be clinically significant in the cat.


Assuntos
Carcinoma/veterinária , Doenças do Gato/patologia , Neoplasias Mamárias Animais , Mioepitelioma/veterinária , Animais , Biomarcadores Tumorais , Proteínas de Ligação ao Cálcio/imunologia , Proteínas de Ligação ao Cálcio/metabolismo , Carcinoma/patologia , Carcinoma Ductal/patologia , Carcinoma Ductal/veterinária , Carcinossarcoma/patologia , Carcinossarcoma/veterinária , Gatos , Cães , Feminino , Imuno-Histoquímica , Queratinas/imunologia , Queratinas/metabolismo , Neoplasias Mamárias Animais/patologia , Proteínas dos Microfilamentos/imunologia , Proteínas dos Microfilamentos/metabolismo , Mioepitelioma/patologia , Sarcoma/patologia , Sarcoma/veterinária , Vimentina/imunologia , Vimentina/metabolismo , Calponinas
8.
Dermatol Surg ; 45 Suppl 2: S57-S69, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31764292

RESUMO

BACKGROUND: Mohs micrographic surgery (MMS) is the most reliable tissue-sparing technique in the management of cutaneous malignancies. Although the concept is simple, there is considerable variability in the mapping and processing techniques used by Mohs surgeons and histotechnicians. OBJECTIVE: This review article aims to examine the frozen-section tissue processing techniques. Existing variations will be discussed and pearls offered to optimize the frozen processing technique. METHODS: A PubMed search was performed for publications on methods of tissue processing in MMS. RESULTS: Our review highlights variations in debulking, embedding, processing adipose tissue, cartilage, and wedge resections. We offer pearls on how to avoid false-positive and false-negative margins and discuss advances in immunohistochemistry. CONCLUSION: Our article provides a how-to format on the different stages of tissue processing with pearls and techniques to optimize practice and improve accuracy.


Assuntos
Secções Congeladas/métodos , Cirurgia de Mohs/métodos , Neoplasias Cutâneas/cirurgia , Anticorpos/análise , Corantes , Procedimentos Cirúrgicos de Citorredução , Secções Congeladas/normas , Humanos , Imuno-Histoquímica/métodos , Queratinas/imunologia , Margens de Excisão , Cirurgia de Mohs/normas , Controle de Qualidade , Cloreto de Tolônio
9.
Mol Immunol ; 116: 1-10, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31561060

RESUMO

Keratin is a cytoskeletal protein that constitutes the intermediate filament. Its distribution is restricted to epithelial tissues in mammals, but is wider in fish. An interesting feature of fish keratin is that it is abundant in the cutaneous mucus. However, the biological function of keratin in the mucus has not been explored. In the present study, we hypothesized that mucus keratins of fugu Takifugu rubripes function as antimicrobial molecules. To verify this hypothesis, we first identified all of the keratins expressed in the epidermis and present in mucus. Five of 15 keratins including Tr-K4 expressed in the epidermis were identified in the mucus. Subsequently, we examined the interaction of keratin molecules present in fugu mucus with yeast. Affinity chromatography using yeast as a carrier and subsequent LC-MS/MS analysis revealed that three types of keratin were bound to the yeast. Furthermore, yeast incubated with fugu mucus was agglutinated, and this was inhibited by anti-recombinant Tr-K4 (rTr-K4) antibody. Immunohistochemical analysis also revealed that keratin was attached to the surface of agglutinated yeasts. These findings indicate that mucus keratin agglutinates yeast. Furthermore, we found insoluble clumps in fugu mucus, which were mainly comprised of keratin. After incubation of yeast with soluble mucus fraction, insoluble clumps incorporating yeast were formed. This observation suggests that fugu mucus keratin sequesters microbes into insoluble clumps, which are eventually eliminated from the mucus. Here, we present our finding of the novel function of keratin as a defense molecule in fish mucus.


Assuntos
Proteínas do Citoesqueleto/imunologia , Proteínas de Peixes/imunologia , Fungos/imunologia , Queratinas/imunologia , Muco/imunologia , Takifugu/imunologia , Animais , Cromatografia Líquida/métodos , Mamíferos/imunologia , Espectrometria de Massas em Tandem/métodos
11.
Cells ; 8(5)2019 05 23.
Artigo em Inglês | MEDLINE | ID: mdl-31126068

RESUMO

Intermediate filament (IF) proteins make up the largest family of cytoskeletal proteins in metazoans, and are traditionally known for their roles in fostering structural integrity in cells and tissues. Remarkably, individual IF genes are tightly regulated in a fashion that reflects the type of tissue, its developmental and differentiation stages, and biological context. In cancer, IF proteins serve as diagnostic markers, as tumor cells partially retain their original signature expression of IF proteins. However, there are also characteristic alterations in IF gene expression and protein regulation. The use of high throughput analytics suggests that tumor-associated alterations in IF gene expression have prognostic value. Parallel research is also showing that IF proteins directly and significantly impact several key cellular properties, including proliferation, death, migration, and invasiveness, with a demonstrated impact on the development, progression, and characteristics of various tumors. In this review, we draw from recent studies focused on three IF proteins most associated with cancer (keratins, vimentin, and nestin) to highlight how several "hallmarks of cancer" described by Hanahan and Weinberg are impacted by IF proteins. The evidence already in hand establishes that IF proteins function beyond their classical roles as markers and serve as effectors of tumorigenesis.


Assuntos
Carcinogênese/metabolismo , Filamentos Intermediários/genética , Filamentos Intermediários/metabolismo , Queratinas/metabolismo , Metástase Neoplásica/fisiopatologia , Nestina/metabolismo , Vimentina/metabolismo , Animais , Carcinogênese/genética , Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Humanos , Imunidade Inata , Inflamação/imunologia , Inflamação/metabolismo , Queratinas/genética , Queratinas/imunologia , Camundongos , Metástase Neoplásica/genética , Neovascularização Patológica/metabolismo , Nestina/genética , Vimentina/genética
12.
Reumatismo ; 71(1): 1-12, 2019 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-30932437

RESUMO

Rheumatoid factor and antibodies against cyclic citrullinated peptides represent a diagnostic hallmark in rheumatoid arthritis (RA). However, over the last decades many other autoantibodies have been identified. Several proteins can trigger an aberrant autoimmune response in their native form while others acquire this feature after post-translational modifications such as citrullination, carbamylation or acetylation. It is of interest that also the enzymes catalyzing such post-translational modifications (e.g. the protein arginine deiminases) can transform themselves into autoantibodies in RA. The purpose of this review article is to provide an overview of relevant literature published over the last years regarding novel autoantibodies and their possible diagnostic and prognostic significance in RA.


Assuntos
Autoanticorpos/metabolismo , Citrulinação , Peptídeos Cíclicos/imunologia , Vimentina/imunologia , Anticorpos Antinucleares/imunologia , Anticorpos Antinucleares/metabolismo , Especificidade de Anticorpos , Artrite Reumatoide/imunologia , Autoanticorpos/imunologia , Antígenos Nucleares do Vírus Epstein-Barr/imunologia , Antígenos Nucleares do Vírus Epstein-Barr/metabolismo , Humanos , Hidrolases/imunologia , Hidrolases/metabolismo , Queratinas/imunologia , Fragmentos de Peptídeos/imunologia , Fragmentos de Peptídeos/metabolismo , Carbamilação de Proteínas , Fator Reumatoide , Vimentina/metabolismo , Proteínas Virais/imunologia , Proteínas Virais/metabolismo
13.
Sci Rep ; 9(1): 1943, 2019 02 13.
Artigo em Inglês | MEDLINE | ID: mdl-30760780

RESUMO

Keratin 15 (K15), a type I keratin, which pairs with K5 in epidermis, has been used extensively as a biomarker for stem cells. Two commercial antibodies, LHK15, a mouse monoclonal and EPR1614Y, a rabbit monoclonal, have been widely employed to study K15 expression. Here we report differential reactivity of these antibodies on epithelial cells and tissue sections. Although the two antibodies specifically recognised K15 on western blot, they reacted differently on skin sections and cell lines. LHK15 reacted in patches, whereas EPR1614Y reacted homogenously with the basal keratinocytes in skin sections. In cultured cells, LHK15 did not react with K15 deficient NEB-1, KEB-11, MCF-7 and SW13 cells expressing only exogenous K8 and K18 but reacted when these cells were transduced with K15. On the other hand, EPR1614Y reacted with these cells even though they were devoid of K15. Taken together these results suggest that EPR1614Y recognises a conformational epitope on keratin filaments which can be reconstituted by other keratins as well as by K15. In conclusion, this report highlights that all commercially available antibodies may not be equally specific in identifying the K15 positive stem cell.


Assuntos
Especificidade de Anticorpos/imunologia , Queratina-15/imunologia , Queratinas/imunologia , Animais , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/metabolismo , Western Blotting , Linhagem Celular , Células Cultivadas , Reações Cruzadas/imunologia , Proteínas do Citoesqueleto/metabolismo , Células Epidérmicas/metabolismo , Epiderme/metabolismo , Células Epiteliais/imunologia , Células Epiteliais/metabolismo , Humanos , Filamentos Intermediários/metabolismo , Queratina-15/metabolismo , Queratinócitos/imunologia , Queratinas/metabolismo , Sensibilidade e Especificidade , Pele/metabolismo , Células-Tronco/imunologia
14.
Clin Rheumatol ; 38(7): 1841-1849, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30810911

RESUMO

OBJECTIVES: Anti-keratin antibody (AKA) is a serum antibody for patients with rheumatoid arthritis (RA), and it has a high specificity. Diagnostic role of AKA in RA was evaluated in this study. METHODS: PubMed, EMBASE, and Web of Science were searched to acquire eligible studies. Articles published before 15 March 2018 were considered to be included. Quality Assessment of Diagnostic Accuracy Studies 2 was used to evaluate the risk of bias and application concern of the included articles. Pooled analysis of diagnostic indicators of AKA for RA was conducted by using a random effects model. Subgroup analysis was employed to explore the potential influencing factors. RevMan 5.3, Stata 11.0, and Meta-DiSc 1.4 software were used in this study. RESULTS: A total of 15 studies (2350 positive and 2067 negative participants) were included. The pooled sensitivity was 0.46 (95% CI 0.44-0.48), pooled specificity was 0.94 (95% CI 0.93-0.95), and pooled diagnostic odds ratio was 15.86 (95% CI 9.48-26.52). In addition, the area under the curve was 0.7194. CONCLUSIONS: The current evidence indicated that AKA has high diagnostic specificity in RA and may be useful for RA diagnostic application in clinic.


Assuntos
Artrite Reumatoide/diagnóstico , Autoanticorpos/análise , Queratinas/imunologia , Artrite Reumatoide/sangue , Técnica Indireta de Fluorescência para Anticorpo , Humanos , Sensibilidade e Especificidade
15.
PLoS One ; 13(11): e0206569, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30485294

RESUMO

Multiple fossil discoveries and taphonomic experiments have established the durability of keratin. The utility and specificity of antibodies to identify keratin peptides has also been established, both in extant feathers under varying treatment conditions, and in feathers from extinct organisms. Here, we show localization of feather-keratin antibodies to control and heat-treated feathers, testifying to the repeatability of initial data supporting the preservation potential of keratin. We then show new data at higher resolution that demonstrates the specific response of these antibodies to the feather matrix, we support the presence of protein in heat-treated feathers using ToF-SIMS, and we apply these methods to a fossil feather preserved in the unusual environment of sinter hot springs. We stress the importance of employing realistic conditions such as sediment burial when designing experiments intended as proxies for taphonomic processes occurring in the fossil record. Our data support the hypothesis that keratin, particularly the ß-keratin that comprises feathers, has potential to preserve in fossil remains.


Assuntos
Plumas , Fósseis , Queratinas , Animais , Anticorpos , Plumas/química , Plumas/imunologia , Plumas/ultraestrutura , Fósseis/ultraestrutura , Fontes Termais , Temperatura Alta , Queratinas/química , Queratinas/imunologia , Tetra-Hidroisoquinolinas , Fatores de Tempo
16.
Medicine (Baltimore) ; 97(40): e12548, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30290612

RESUMO

RATIONALE: Most cases of primary liver cancer involve hepatocellular carcinoma (HCC). Lymphoepithelioma-like carcinoma (LELC) is defined as a tumor composed of undifferentiated epithelial cells with a prominent lymphoid infiltrate, which is rarely reported. Lymphoepithelioma-like HCC (LEL-HCC) is an uncommon variant of HCC, having an unclear process of development. Here, we report the first case involving simultaneous HCC and LEL-HCC. PATIENT CONCERNS: A 77-year-old female was accidentally found to have a hypoechoic hepatic nodule via an abdominal ultrasound during a health examination. Abdominal computed tomography scan revealed 2 hepatic nodules with arterial phase enhancement and washout in the late phase. DIAGNOSES: We diagnosed the case with 2 distinct liver nodules, HCC and LEL-HCC. INTERVENTIONS: With suspicion of HCC, tumor resection (liver segments 4 and 5) was then performed. Histopathological examination of tumor 1 showed a moderately differentiated HCC and tumor 2 demonstrated a LEL-HCC. Immunohistochemically, the cells of tumor 2 were immunoreactive for cytokeratin (CK), CK7, and CK19. Epstein-Barr virus encoding small RNA (EBER) in situ hybridization results were negative. OUTCOMES: Six months after resection, intrahepatic tumor recurrence was noted. Radiofrequency ablation was conducted. LESSONS: This is an interesting case providing circumstantial evidence of simultaneous development of HCC and LEL-HCC in distinct nodules of the liver with a background of chronic hepatitis B virus infection.


Assuntos
Carcinoma Hepatocelular/patologia , Neoplasias Hepáticas/patologia , Idoso , Carcinoma Hepatocelular/complicações , Carcinoma Hepatocelular/cirurgia , Feminino , Hepatite B Crônica/complicações , Humanos , Queratinas/imunologia , Neoplasias Hepáticas/complicações , Neoplasias Hepáticas/cirurgia
17.
Nat Commun ; 9(1): 3437, 2018 08 24.
Artigo em Inglês | MEDLINE | ID: mdl-30143634

RESUMO

Keratin 76 (Krt76) is expressed in the differentiated epithelial layers of skin, oral cavity and squamous stomach. Krt76 downregulation in human oral squamous cell carcinomas (OSCC) correlates with poor prognosis. We show that genetic ablation of Krt76 in mice leads to spleen and lymph node enlargement, an increase in regulatory T cells (Tregs) and high levels of pro-inflammatory cytokines. Krt76-/- Tregs have increased suppressive ability correlated with increased CD39 and CD73 expression, while their effector T cells are less proliferative than controls. Loss of Krt76 increases carcinogen-induced tumours in tongue and squamous stomach. Carcinogenesis is further increased when Treg levels are elevated experimentally. The carcinogenesis response includes upregulation of pro-inflammatory cytokines and enhanced accumulation of Tregs in the tumour microenvironment. Tregs also accumulate in human OSCC exhibiting Krt76 loss. Our study highlights the role of epithelial cells in modulating carcinogenesis via communication with cells of the immune system.


Assuntos
Queratinas/imunologia , Neoplasias Bucais/imunologia , Neoplasias Gástricas/imunologia , 5'-Nucleotidase/metabolismo , Animais , Antígenos CD/metabolismo , Apirase/metabolismo , Linhagem Celular Tumoral , Feminino , Citometria de Fluxo , Imunofluorescência , Humanos , Hibridização in Situ Fluorescente , Técnicas In Vitro , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Mutantes , Linfócitos T Reguladores/metabolismo
18.
Front Immunol ; 9: 858, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29922278

RESUMO

Pemphigus vulgaris (PV) is a potentially lethal autoimmune disease characterized by blister formation of the skin and mucous membranes and is caused by autoantibodies against desmoglein (Dsg) 1 and Dsg3. Dsg1 and Dsg3 are linked to keratin filaments in desmosomes, adhering junctions abundant in tissues exposed to high levels of mechanical stress. The binding of the autoantibodies leads to internalization of Dsg3 and a collapse of the keratin cytoskeleton-yet, the relevance and interdependence of these changes for loss of cell-cell adhesion and blistering is poorly understood. In live-cell imaging studies, loss of the keratin network at the cell periphery was detectable starting after 60 min of incubation with immunoglobulin G fractions of PV patients (PV-IgG). These rapid changes correlated with loss of cell-cell adhesion detected by dispase-based dissociation assays and were followed by a condensation of keratin filaments into thick bundles after several hours. Dsg3 internalization started at 90 min of PV-IgG treatment, thus following the early keratin changes. By inhibiting casein kinase 1 (CK-1), we provoked keratin alterations resembling the effects of PV-IgG. Although CK-1-induced loss of peripheral keratin network correlated with loss of cell cohesion and Dsg3 clustering in the membrane, it was not sufficient to trigger the internalization of Dsg3. However, additional incubation with PV-IgG was effective to promote Dsg3 loss at the membrane, indicating that Dsg3 internalization is independent from keratin alterations. Vice versa, inhibiting Dsg3 internalization did not prevent PV-IgG-induced keratin retraction and only partially rescued cell cohesion. Together, keratin changes appear very early after autoantibody binding and temporally overlap with loss of cell cohesion. These early alterations appear to be distinct from Dsg3 internalization, suggesting a crucial role for initial loss of cell cohesion in PV.


Assuntos
Autoanticorpos/imunologia , Desmogleína 3/imunologia , Queratinas/imunologia , Pênfigo/imunologia , Pele/imunologia , Autoanticorpos/sangue , Autoantígenos/imunologia , Adesão Celular/imunologia , Linhagem Celular , Desmogleína 1/imunologia , Desmogleína 3/metabolismo , Endocitose/imunologia , Humanos , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Filamentos Intermediários/imunologia , Filamentos Intermediários/metabolismo , Queratinócitos , Queratinas/metabolismo , Pênfigo/sangue , Pênfigo/patologia , Pele/citologia , Pele/patologia
19.
Ann Hematol ; 97(2): 327-334, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29150810

RESUMO

The aims of this study are to determine the replacement rate of damaged hepatocytes by donor-derived cells in sex-mismatched recipient patients with thalassemia major and to determine whether co-transplantation of mesenchymal stem cells and hematopoietic stem cells (HSCs) can alleviate liver fibrosis. Ten sex-mismatched donor-recipient pairs who received co-transplantation of HSCs with mesenchymal stem cells were included in our study. Liver biopsy was performed before transplantation. Two other liver biopsies were performed between 2 and 5 years after transplantation. The specimens were studied for the presence of donor-derived epithelial cells or hepatocytes using fluorescence in situ hybridization by X- and Y-centromeric probes and immunohistochemical staining for pancytokeratin, CD45, and a hepatocyte-specific antigen. All sex-mismatched tissue samples demonstrated donor-derived hepatocyte independent of donor gender. XY-positive epithelial cells or hepatocytes accounted for 11 to 25% of the cells in histologic sections of female recipients in the first follow-up. It rose to 47-95% in the second follow-up. Although not statistically significant, four out of ten patients showed signs of improvement in liver fibrosis. Our results showed that co-transplantation of HSC with mesenchymal stem cells increases the rate of replacement of recipient hepatocytes by donor-derived cells and may improve liver fibrosis.


Assuntos
Transplante de Células-Tronco Hematopoéticas , Hepatócitos/imunologia , Cirrose Hepática/terapia , Transplante de Células-Tronco Mesenquimais , Talassemia beta/terapia , Adolescente , Adulto , Antígenos de Neoplasias/genética , Antígenos de Neoplasias/imunologia , Biomarcadores/metabolismo , Biópsia , Criança , Células Epiteliais/imunologia , Células Epiteliais/patologia , Feminino , Células-Tronco Hematopoéticas/citologia , Células-Tronco Hematopoéticas/imunologia , Hepatócitos/patologia , Humanos , Hibridização in Situ Fluorescente , Queratinas/genética , Queratinas/imunologia , Antígenos Comuns de Leucócito/genética , Antígenos Comuns de Leucócito/imunologia , Cirrose Hepática/imunologia , Cirrose Hepática/patologia , Masculino , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/imunologia , Estudos Retrospectivos , Doadores de Tecidos , Quimeras de Transplante , Transplante Homólogo , Talassemia beta/imunologia , Talassemia beta/patologia
20.
Methods Mol Biol ; 1634: 235-246, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28819856

RESUMO

Circulating tumor cell (CTC) as an important component in "liquid biopsy" holds crucial clinical relevance in cancer prognosis, treatment efficiency evaluation, prediction and potentially early detection. Here, we present a Fiber-optic Array Scanning Technology (FAST) that enables antigen-agnostic, size-agnostic detection of CTC. By immunofluorescence staining detection of a combination of a panel of markers, FAST technology can be applied to detect rare CTC in non-small cell lung cancer (NSCLC) setting with high sensitivity and specificity. In combination with Automated Digital Microscopy (ADM) platform, companion markers on CTC such as Vimentin and Programmed death-ligand 1 (PD-L1) can also be analyzed to further characterize these CTCs. FAST data output is also compatible with downstream single cell picking platforms. Single cell can be isolated post ADM confirmation and used for "actionable" genetic mutations analysis.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/diagnóstico , Tecnologia de Fibra Óptica/métodos , Imunofluorescência/métodos , Neoplasias Pulmonares/diagnóstico , Células Neoplásicas Circulantes/patologia , Análise de Célula Única/métodos , Anticorpos Monoclonais/química , Antígeno B7-H1/genética , Antígeno B7-H1/imunologia , Antígeno B7-H1/metabolismo , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/imunologia , Biomarcadores Tumorais/metabolismo , Carcinoma Pulmonar de Células não Pequenas/sangue , Carcinoma Pulmonar de Células não Pequenas/imunologia , Carcinoma Pulmonar de Células não Pequenas/patologia , Linhagem Celular Tumoral , Detecção Precoce de Câncer , Tecnologia de Fibra Óptica/instrumentação , Imunofluorescência/instrumentação , Corantes Fluorescentes/química , Humanos , Queratinas/genética , Queratinas/imunologia , Queratinas/metabolismo , Antígenos Comuns de Leucócito/genética , Antígenos Comuns de Leucócito/imunologia , Antígenos Comuns de Leucócito/metabolismo , Leucócitos Mononucleares/citologia , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Neoplasias Pulmonares/sangue , Neoplasias Pulmonares/imunologia , Neoplasias Pulmonares/patologia , Mucina-1/genética , Mucina-1/imunologia , Mucina-1/metabolismo , Células Neoplásicas Circulantes/imunologia , Células Neoplásicas Circulantes/metabolismo , Receptor ErbB-2/genética , Receptor ErbB-2/imunologia , Receptor ErbB-2/metabolismo , Sensibilidade e Especificidade , Análise de Célula Única/instrumentação , Vimentina/genética , Vimentina/imunologia , Vimentina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA